NAPSA Antikörper (AA 20-158)

Produktnummer ABIN1845258

Produktdetails anti-NAPSA Antikörper

Target: NAPSA (Napsin A Aspartic Peptidase (NAPSA))

Bindungsspezifität: AA 20-158

Reaktivität: Human, Ratte

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser NAPSA Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Aufreinigung: Purified antibody

Immunogen: Purified recombinant fragment of human NAPSA (AA: 20-158) expressed in E. coli.

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.0 mg/mL

Buffer: PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.

Details zu NAPSA

Target: NAPSA (Napsin A Aspartic Peptidase (NAPSA))

Andere Bezeichnung: NAPSA (NAPSA Produkte)

Hintergrund: The activation peptides of aspartic proteinases plays role as inhibitors of the active site.These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens.The pronapsin A gene is expressed predominantly in lung and kidney.Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.

Molekulargewicht: 45.4 kDa

Gen-ID: 9476

Pathways: Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis